Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Sues 10 Firms for Infringement on a Method to Determine Haplotype


This story has been updated from a previous version posted May 26 to include information from the court documents.

Australian genetic testing company Genetic Technologies has sued 10 firms, including 454 Life Sciences, for infringing a patent it holds on method to determine haplotype information from non-coding DNA.

The other firms named in the suit, which was filed this week in the US District Court for the District of Colorado, are Agilent, Bristol-Myers Squibb, Eurofins, GlaxoSmithKline, Hologic, Merial, Navigenics, Neogen, and Pfizer.

Genetic Technologies is alleging infringement of its US Patent No. 5,612,179, titled "Intron Sequence Analysis Method for Detection of Adjacent Locus Alleles as Haplotypes."

While the '179 Patent expired on March 9, 2010, Genetic Technologies is entitled to collect damages for past infringement occurring during the term of the patent.

In documents filed with the court, Genetic Technologies gave an example of how it claims 454 has infringed on its patent. In a 2009 study, the GS FLX was used in a resequencing study of genes thought to be involved with type 1 diabetes, including the sequencing of the multi-allelic gene IFIH1. Genetic Technologies claims that the sequencing and subsequent analysis of the non-coding region of that gene infringed at least one claim of the '179 patent.

Genetic Technologies' suit follows a previous suit filed in January against six companies for the infringement of the same patent.

Both suits follow a suit filed in February 2010 against several firms that was concluded last month. The company said it has secured around $14.5 million in licensing revenues since filing that suit.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.